Introduction
The host response to malignant tumours is usually considered to be primarily a function of the cellular part of the immune system. Hypersensitivity skin testing, graft rejection, or, in vitro, the lymphocyte response to phytohaemagglutinin may all be used to measure the integrity of this system, but hypersensitivity skin tests are simple, reproducible, and easy to interpret. Patients 
Discussion
Our data confirm that cellular immunity is impaired in these three types of tumours. Though the depression occurred on both Mantoux and DNCB testing the differences were consistently more obvious with the DNCB test.
There were important differences between the two control groups such that if the whole breast cancer group was compared with the gastrointestinal control group there were no significant differences in either Mantoux or DNCB response gradings. This difference between the control groups was probably related to general ill health since patients requiring operation for gastrointestinal disease tend to be more ill than patients with benign breast disease. Obviously, misleading results may be obtained if normal patients are used as controls for some malignancies. Can this depression of cellular immune response be related to prognosis? While the prognosis of malignancy is clearly related to the outcome of the interplay of host and tumour little is known of the basic factors involved in this interaction. The idea that general immune competence plays a part would be supported if the changes in immune competence in different tumours corresponded to the outcome seen in that type. Broadly speaking, prognosis is similar for breast and colonic tumours of equivalent stage but very much worse for gastric cancer. The depression of cellular immunity in gastric cancer, however, consistently lay between that seen for breast (least depression) and colonic (greatest depression) cancers. Thus, depression of cellular immune competence alone cannot explain the different prognoses of gastric and colonic cancer. The possibility that on the tumour side of the equation the different sites are so disparate as to mask the effects of immune competence is not excluded; but the stage-related findings in breast cancer were also against general immune competence playing an important part in determining or reflecting prognosis, though only prolonged prospective follow-up can give an answer in relation to individual cases of early cancer. The differences between breast and gastrointestinal cancers were unlikely to be related to sex differences since normal men consistently have a better response to the Mantoux test. 8 Some workers9 10 have suggested that depression of cellular immunity is stage related though the data are not extensive. Our figures showed an insignificant tendency in this direction in colonic cancer. In the patients with breast cancer it is difficult to assess the significance of variations between the different stages. Clearly, neither total volume of tumour nor the presence of lymph node metastases was closely related to immune depression either in the breast or gastrointestinal cases. There is no clear explanation for the curious findings in the breast cancer patients. It would be tempting to suggest that some of the small tumours with a poor response had occult metastases and so really belonged to stage D; the corresponding argument to explain the good response of the large tumours would be that a good immune response had facilitated control of dissemination but had been unable to prevent continued local growth of the primary tumour. Follow-up of these patients, however, showed that the prognosis of the patients with a large local tumour and lymph node metastases (stage C,) was extremely poor in spite of the well maintained cellular immunity. The difference between small and large tumours is so clearcut that it cannot be ignored, and it seems that these differences must reflect some facets of the biological processes in the host tumour interrelationship that are not understood.
The considerably depressed responses in gastrointestinal cancer might suggest a nutritional effect. Nutritional factors and general "illness" undoubtedly play some part (as seen in the different control groups) but if they were the only factors involved the most profound depression would be expected to occur in gastric rather than colonic cancer. Depressed immunity seems to result from a summation of at least two effectsnutritional factors and some specific effect of the tumour itself. The view that the latter may be the more important of the two would be supported by the finding that cellular immunity returns to normal after curative surgery. But though this sometimes occurs it is by no means invariably seen.
Thus, the changes in cellular immunity in cancer are complex and vary between different tumours. It would be easy to dismiss them as random and of little importance but they probably point to the fact that the host tumour interaction is more complex than is commonly believed. Tables, 1959-61. 
